Sandham, D., Chen, W., Hardman, C., Luo, J., Xue, L., Ogg, G., & Erpenbeck, V. (2019). Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s). Wiley.
Chicago Style (17th ed.) CitationSandham, D., W. Chen, C. Hardman, J. Luo, L. Xue, G. Ogg, and V. Erpenbeck. Fevipiprant Inhibits Prostaglandin D2 Mediated Activation of Group 2 Innate Lymphoid Cells (ILC2s). Wiley, 2019.
MLA引文Sandham, D., et al. Fevipiprant Inhibits Prostaglandin D2 Mediated Activation of Group 2 Innate Lymphoid Cells (ILC2s). Wiley, 2019.
警告:這些引文格式不一定是100%准確.